PLASMA Act
3/20/2025, 3:23 AMSummary of Bill S 694
Bill 119 s 694, also known as the Plasma-Derived Products Manufacturer Discount Program Phase-In Act, is a proposed amendment to Title XVIII of the Social Security Act. The main purpose of this bill is to gradually implement a discount program for manufacturers of plasma-derived products.Currently, there is a discount program in place for manufacturers of certain drugs under Medicare Part B. This bill seeks to extend this program to include plasma-derived products, which are essential for treating a variety of medical conditions.
The bill outlines a phased approach to implementing this discount program for plasma-derived products. This means that manufacturers will gradually be required to provide discounts on these products over a period of time, rather than all at once. The goal of this bill is to make these life-saving products more affordable for patients who rely on them for their medical treatment. By including plasma-derived products in the manufacturer discount program, it is hoped that patients will have better access to these essential medications. Overall, Bill 119 s 694 aims to improve access to plasma-derived products for Medicare beneficiaries by implementing a phased-in discount program for manufacturers. This bill is an important step towards making healthcare more affordable and accessible for all Americans.
Read the Full Bill
Current Status of Bill S 694
Bill S 694 is currently in the status of Bill Introduced since February 24, 2025. Bill S 694 was introduced during Congress 119 and was introduced to the Senate on February 24, 2025. Bill S 694's most recent activity was Read twice and referred to the Committee on Finance. as of February 24, 2025Bipartisan Support of Bill S 694
Total Number of Sponsors
2Democrat Sponsors
0Republican Sponsors
2Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 694
Primary Policy Focus
Alternate Title(s) of Bill S 694
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.Comments
Most relevant
Sponsors and Cosponsors of S 694
Latest Bills
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
Bill S 717March 20, 2025
Taiwan Travel and Tourism Coordination Act
Bill S 733March 20, 2025
GENIUS Act of 2025
Bill S 919March 20, 2025
Mining Waste, Fraud, and Abuse Prevention Act of 2025
Bill HR 1865March 20, 2025
Lieutenant Osvaldo Albarati Stopping Prison Contraband Act
Bill S 736March 20, 2025
Dangerous Viral Gain of Function Research Moratorium Act
Bill S 738March 20, 2025
9/11 Responder and Survivor Health Funding Correction Act of 2025
Bill S 739March 20, 2025
PLASMA Act
Bill S 694March 20, 2025
Edward J. Dwight, Jr. Congressional Gold Medal Act of 2025
Bill S 734March 20, 2025
Broadband Buildout Accountability Act
Bill S 713March 20, 2025